01—Abstract
Summary
Summary of the 8-K filed October 29, 2025. Cited figures are marked; the original filing is the authoritative source.
Fortive Corporation reported third-quarter 2025 results for the quarter ended September 26, 2025, in a press release furnished as Exhibit 99.1.
Revenue was $1.03 billiona, up 2.3% year-over-year (core revenue up 1.9%). GAAP net income from continuing operations was $117 million, an 11.4% margin, and adjusted EBITDA was $309 million, a 30.1% margin, up 10.4%. GAAP diluted EPS from continuing operations was $0.35, up 9.4%, and adjusted diluted EPS was $0.68, up 15.3%.
Operating cash flow was $295 millionb and free cash flow was $266 million. Net earnings from discontinued operations was a loss of $62.0 million in the quarter, and the balance sheet shows cash and equivalents of $430.8 million and current portion of long-term debt of $1,189.2 million. The company executed $1.0 billion of share repurchases in the quarter, comprising 21 million shares and representing approximately 6% of diluted shares outstanding.
Management raised its full-year 2025 adjusted diluted EPS guidance to $2.63 to $2.67c from the prior $2.50 to $2.60 range. The results reflect the company's first quarter as a simpler, more focused company following the June 28, 2025 separation of its former Precision Technologies segment through the distribution of Ralliant Corporation common stock to shareholders. Management describes its Fortive Accelerated strategy as now in execution mode.
Segment results were mixed in the quarter. Intelligent Operating Solutions revenue was $699 milliond, up 2.6%, with adjusted EBITDA of $242 million and a 34.6% margin.
Advanced Healthcare Solutions revenue was $328 million, up 1.9%, with adjusted EBITDA of $92 million and a 28.1% margin. Unallocated 'Other' operating costs rose to $63.6 million from $33.7 million a year earlier.
02—Key points
Key Highlights
- Q3 2025 revenue of $1.03 billion, up 2.3% year-over-year, with core revenue up 1.9%
- GAAP diluted EPS from continuing operations of $0.35, up 9.4%; adjusted diluted EPS of $0.68, up 15.3%
- Adjusted EBITDA of $309 million, a 30.1% margin, up 10.4% year-over-year
- Raised full-year 2025 adjusted diluted EPS guidance to $2.63 to $2.67, from $2.50 to $2.60
- Executed $1.0 billion of share repurchases, comprising 21 million shares, or about 6% of diluted shares outstanding
- Q3 operating cash flow of $295 million and free cash flow of $266 million; trailing twelve-month free cash flow of $922 million
- Net loss from discontinued operations of $62.0 million in Q3 2025, following the June 28, 2025 Ralliant separation
03—Questions
Frequently Asked Questions
How did Fortive perform in the third quarter of 2025?
Revenue was $1.03 billion, up 2.3% year-over-year, and core revenue rose 1.9%. GAAP net income from continuing operations was $117 million, and adjusted EBITDA was $309 million, a 30.1% margin, up 10.4%. Adjusted diluted EPS was $0.68, up 15.3%.
Did Fortive change its full-year 2025 outlook?
Yes. The company raised its full-year 2025 adjusted diluted net EPS expectation to $2.63 to $2.67, compared with its prior expectation of $2.50 to $2.60, to reflect strong third-quarter adjusted EPS performance.
How much capital did Fortive return to shareholders?
The company executed $1.0 billion of share repurchases in the third quarter, comprising 21 million shares and representing about 6% of diluted shares outstanding. The filing also states that the company deployed $1.0 billion toward share repurchases in the quarter.
What is the Ralliant separation and how does it affect reported results?
On June 28, 2025, Fortive distributed to its shareholders all of the outstanding common stock of Ralliant Corporation, the entity holding its former Precision Technologies businesses. The Ralliant business is reported as discontinued operations, and the results discussed in the release refer to continuing operations unless otherwise indicated. Net earnings from discontinued operations was a loss of $62.0 million in the third quarter.
How did the two reportable segments perform?
Intelligent Operating Solutions generated revenue of $699 million, up 2.6%, with GAAP operating profit of $181 million, a 25.9% operating margin, and adjusted EBITDA of $242 million, a 34.6% margin. Advanced Healthcare Solutions generated revenue of $328 million, up 1.9%, with GAAP operating profit of $43 million, a 12.9% operating margin, and adjusted EBITDA of $92 million, a 28.1% margin.
04—Continue